Literature DB >> 12226540

The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease.

P Grammas1, M Yamada, B Zlokovic.   

Abstract

Neuronal cell death is the primary underlying pathogenic lesion in Alzheimer's disease (AD). Despite intense research efforts, the mechanisms that contribute to neuronal cell death have not been clarified. In this debate we address the question, Is AD a vascular or metabolic disorder? Here we defend the hypothesis that the cerebromicrovasculature is a key player in the pathogenesis of AD. Evidence is presented that vascular amyloid beta (Abeta) is more closely associated with tau pathology than the distribution of diffuse or neuritic plaque Abeta. Furthermore, brain endothelial cells are identified as important regulators of the neuronal microenvironment, including Abeta levels. Finally, evidence is presented that brain endothelial cells undergo cellular and biochemical changes in AD and that the release of neurotoxic factors from these dysfunctional cells contributes to the neuronal cell loss characteristic of AD.

Entities:  

Mesh:

Year:  2002        PMID: 12226540     DOI: 10.3233/jad-2002-4311

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  21 in total

1.  Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.

Authors:  Gene L Bowman; Joseph F Quinn
Journal:  Aging health       Date:  2008-02-01

Review 2.  Diverse roles of the vasculature within the neural stem cell niche.

Authors:  Joshua S Goldberg; Karen K Hirschi
Journal:  Regen Med       Date:  2009-11       Impact factor: 3.806

3.  Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease.

Authors:  Xiangling Yin; Jill Wright; Trevor Wall; Paula Grammas
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

4.  Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy.

Authors:  Parham Moftakhar; Matthew D Lynch; Justine L Pomakian; Harry V Vinters
Journal:  J Neuropathol Exp Neurol       Date:  2010-12       Impact factor: 3.685

5.  Efflux transport of serum amyloid P component at the blood-brain barrier.

Authors:  Szilvia Veszelka; Judit Laszy; Tamás Pázmány; László Németh; Izabella Obál; László Fábián; Gábor Szabó; Csongor S Abrahám; Mária A Deli; Zoltán Urbányi
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

6.  Cyclooxygenase-3 gene expression in Alzheimer hippocampus and in stressed human neural cells.

Authors:  Jian-Guo Cui; Hitoshi Kuroda; N Vishvanath Chandrasekharan; Ricardo Palacios Pelaez; Daniel L Simmons; Nicolas G Bazan; Walter J Lukiw
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

7.  Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons.

Authors:  Shuzhen Guo; Woo Jean Kim; Josephine Lok; Sun-Ryung Lee; Elaine Besancon; Bing-Hao Luo; Monique F Stins; Xiaoying Wang; Shoukat Dedhar; Eng H Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-21       Impact factor: 11.205

8.  Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial.

Authors:  Pedro J Modrego; Consuelo Rios; José M Pérez Trullen; Maria J García-Gómara; José M Errea
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 9.  Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.

Authors:  Robert D Bell; Berislav V Zlokovic
Journal:  Acta Neuropathol       Date:  2009-03-25       Impact factor: 17.088

10.  Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice.

Authors:  Dimitrije Krstic; Amrita Madhusudan; Jana Doehner; Prisca Vogel; Tina Notter; Claudine Imhof; Abigail Manalastas; Martina Hilfiker; Sandra Pfister; Cornelia Schwerdel; Carsten Riether; Urs Meyer; Irene Knuesel
Journal:  J Neuroinflammation       Date:  2012-07-02       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.